These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 7543171

  • 1. In vivo effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate on the development of atherosclerosis and endothelial dysfunction in cholesterol-fed rabbits.
    Kojda G, Stein D, Kottenberg E, Schnaith EM, Noack E.
    J Cardiovasc Pharmacol; 1995 May; 25(5):763-73. PubMed ID: 7543171
    [Abstract] [Full Text] [Related]

  • 2. Effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate in experimental atherosclerosis.
    Kojda G, Noack E.
    Agents Actions Suppl; 1995 May; 45():201-6. PubMed ID: 7717181
    [Abstract] [Full Text] [Related]

  • 3. The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis.
    Hacker A, Müller S, Meyer W, Kojda G.
    Br J Pharmacol; 2001 Apr; 132(8):1707-14. PubMed ID: 11309242
    [Abstract] [Full Text] [Related]

  • 4. Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion.
    Dragoni S, Gori T, Lisi M, Di Stolfo G, Pautz A, Kleinert H, Parker JD.
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1955-9. PubMed ID: 17641250
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Potency and in vitro tolerance of organic nitrates: partially denitrated metabolites contribute to the tolerance-devoid activity of pentaerythrityl tetranitrate.
    Koenig A, Lange K, Konter J, Daiber A, Stalleicken D, Glusa E, Lehmann J.
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):68-74. PubMed ID: 17666918
    [Abstract] [Full Text] [Related]

  • 14. Effects of nonintermittent treatment of rabbits with pentaerythritol tetranitrate on vascular reactivity and superoxide production.
    Kojda G, Hacker A, Noack E.
    Eur J Pharmacol; 1998 Aug 14; 355(1):23-31. PubMed ID: 9754935
    [Abstract] [Full Text] [Related]

  • 15. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates.
    Daiber A, Oelze M, Coldewey M, Bachschmid M, Wenzel P, Sydow K, Wendt M, Kleschyov AL, Stalleicken D, Ullrich V, Mülsch A, Münzel T.
    Mol Pharmacol; 2004 Dec 14; 66(6):1372-82. PubMed ID: 15331769
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Atherosclerosis progression and standard in coronary disease. Nitrate with special talents: PETN (pentaerythritol tetranitrate) is vasoprotective].
    MMW Fortschr Med; 2002 Nov 07; 144(45):51. PubMed ID: 12534064
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.